Politics

EIBIR launches its Strategic Research Agenda for Biomedical Imaging

The European Institute for Biomedical Imaging Research (EIBIR) has published its Strategic Research Agenda (SRA) for Biomedical Imaging. The agenda identifies current challenges and needs in healthcare, illustrating how biomedical imaging and derived data can help to address these challenges, in order to stimulate dedicated research funding efforts and mechanisms.

Photo

The SRA was developed in collaboration with EIBIR`s shareholders representing scientific societies related to biomedical imaging, as well as EIBIR's Scientific Advisory Board. It identifies and describes five main challenges facing biomedical imaging today, and addresses in detail how these challenges can be overcome.

In particular, the agenda addresses the current paradigm shift in medicine and healthcare, which has moved from a reactive to proactive approaches and solutions by providing predictive, preventive, and personalised medical solutions for the individual patient. It highlights the growing impact of personalised medicine on patients and its ability to address the challenges of ineffective treatment and rising healthcare costs. The SRA also focusses on the growing importance of big data, artificial intelligence, and innovative imaging technologies, emphasising biomedical imaging’s role as a forerunner in the digital transformation of healthcare and as a leading discipline in the adoption of new innovative solutions like deep learning and artificial intelligence.

EIBIR is a nonprofit organisation founded by the European Society of Radiology and supports researchers and industry partners in the preparation and coordination of biomedical imaging research projects throughout Europe. EIBIR comprises a large and diverse landscape of more than 130 network members (universities, hospitals and research organisations) and is committed to supporting the development of biomedical imaging technologies and to the disseminating of knowledge with the ultimate goal of improving the diagnosis, treatment, and prevention of disease.

Through its Strategic Research Agenda for Biomedical Imaging, EIBIR hopes to stimulate and direct funding efforts towards research projects and developments which will address some of the most important challenges facing healthcare in Europe and the rest of the world.

You can read the Strategic Research Agenda for Biomdical Imaging here.

Source: ESR Press Office

08.10.2018

Read all latest stories

Related articles

Global partnership

Philips and Hologic team up for women’s health

Royal Philips, a global leader in health technology, and Hologic, Inc., an innovative women’s health company, announced a global partnership agreement to offer care professionals integrated…

Advanced techniques

Breast cancer: how imaging technology will help avoid unnecessary biopsies

Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center (DKFZ) in Heidelberg. The scientists have combined an advanced method of…

Old technique & new technology

Optoacoustics: the sound of cells

For centuries, hands, eyes and ears were the physicians’ most important instruments when it came to detecting and diagnosing disease. Today, one of the traditional techniques, percussion, is being…

Related products

DR

Agfa - DR 10s detector

Agfa HealthCare

Flatpanel fluoro

Agfa - DR 800 (Fluoroscopy)*

Agfa HealthCare

DR

Agfa - DX-D 300

Agfa HealthCare

DR

Agfa - DX-D 40 detector

Agfa HealthCare